Most Recent

image: Serious Putty

Serious Putty

By | May 1, 2016

A naturally occurring clay, used in traditional Native American medicine, shows promise as an antibiotic.

6 Comments

image: A Weighty Anomaly

A Weighty Anomaly

By | November 1, 2015

Why do some obese people actually experience health benefits?

3 Comments

image: The Upside

The Upside

By | September 1, 2015

Researchers explore the benefits of hearing loss and impairment.

0 Comments

image: Silence of the Lambs

Silence of the Lambs

By | August 1, 2015

A die-off of newborn lambs in Australia leads to the discovery of a new toxin and clues to a devastating liver disease in children.

2 Comments

image: TB over Time

TB over Time

By | August 1, 2015

Eighteenth-century DNA sequences yield insights into the history of tuberculosis infections.

0 Comments

image: The Spleen Collectors

The Spleen Collectors

By | August 1, 2015

Donated organs are helping researchers map out the immune system in humans.

0 Comments

image: A Plague on Pachyderms

A Plague on Pachyderms

By | June 1, 2015

At least seven species of herpesvirus commonly infect elephants. At zoos, keepers scramble to save calves, who are particularly vulnerable to the viruses.

5 Comments

image: HIV in the Internet Age

HIV in the Internet Age

By | May 1, 2015

Social networking sites may facilitate the spread of sexually transmitted disease, but these sites also serve as effective education and prevention tools.

0 Comments

image: Llamas as Lab Rats

Llamas as Lab Rats

By | May 1, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

0 Comments

image: Miraculous Activist

Miraculous Activist

By | May 1, 2015

Timothy Ray Brown, commonly referred to as the “Berlin patient,” does not want to be the only person cured of AIDS.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech